Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer-Letter.
Abstract
Moroz and colleagues showed the antitumor activity of radiolabeled antibodies directed against CDCP1 in preclinical models of pancreatic carcinoma ([1][1]). Pancreatic carcinoma is one of the most aggressive human cancers. Complete surgical resection followed by chemotherapy is the only...
Paper Details
Title
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer-Letter.
Published Date
Oct 15, 2020
Journal
Volume
26
Issue
20
Pages
5539 - 5539
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History